Hepatitis Monthly

Published by: Kowsar

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Seyed Moayed Alavian 1 , * , Behzad Hajarizadeh 2 , Bashir Hajibeigi 2 , Taher Doroudi 2 , Amir Kambiz Hamadanizadeh 2 and Koroush Abar 2
Authors Information
1 Baqiyatallah University of Medical Sciences, Tehran Hepatitis Center, Study Group of Interferonin Iran, manager@iranhepgroup.info, Tehran, IR.Iran
2 Baqiyatallah University of Medical Sciences, Tehran Hepatitis center, Tehran, IR.Iran
Article information
  • Hepatitis Monthly: , 4 (7); 53-58
  • Article Type: Research Article

To Cite: Alavian S, Hajarizadeh B, Hajibeigi B, Doroudi T, Hamadanizadeh A, et al. Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian, Hepat Mon. Online ahead of Print ;4(7):53-58.

Abstract
© 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments